Showing results (161-170 of 231) with videos related to
Sort By:
Pageof 24
AJNR. American Journal of Neuroradiology|June 1, 1997
MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disabilityG J Lycklama à Nijeholt, F Barkhof, P Scheltens, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|July 10, 1999
The diagnostic value of electroencephalography in mild senile Alzheimer's diseaseJ J Claus, R L Strijers, E J Jonkman, et al.The Journal of Prevention of Alzheimer'S Disease|November 29, 2017
Clinical Effects of Tramiprosate in APOE4/4 Homozygous Patients with Mild Alzheimer's Disease Suggest Disease Modification PotentialS Abushakra, A Porsteinsson, P Scheltens, et al.Neurology|September 6, 2007
Longitudinal changes of CSF biomarkers in memory clinic patientsF H Bouwman, W M van der Flier, N S M Schoonenboom, et al.The Journal of Prevention of Alzheimer'S Disease|July 5, 2018
What Have We Learned from Expedition III and EPOCH Trials? Perspective of the CTAD Task ForceP S Aisen, E Siemers, D Michelson, et al.Neurology|November 5, 2010
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest oldT M Polvikoski, E C W van Straaten, F Barkhof, et al.Current Medical Research and Opinion|August 5, 2008
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE studyC Ballard, M Sauter, P Scheltens, et al.Brain : a Journal of Neurology|May 13, 1998
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptomsG J Nijeholt, M A van Walderveen, J A Castelijns, et al.Neurology|March 18, 2009
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measuresW J P Henneman, J D Sluimer, J Barnes, et al.Neuroimage|October 16, 2002
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometryE J Burton, G Karas, S M Paling, et al.Pageof 24